Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China

JAMA - Journal of the American Medical Association

Volumn 323, Issue 19, 2020, Pages 1915-1923

  Pan, An ^a   Liu, Li ^a   Wang, Chaolong ^a   Guo, Huan ^a   Hao, Xingjie ^a   Wang, Qi ^a   Huang, Jiao ^a   He, Na ^b   Yu, Hongjie ^b   Lin, Xihong ^c,d   Wei, Sheng ^a   Wu, Tangchun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CHILD; CHILDHOOD; CHINA; COHORT ANALYSIS; CORONAVIRUS DISEASE 2019; CRITICAL ILLNESS; DISEASE SEVERITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUARANTINE; RISK ASSESSMENT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEX DIFFERENCE; SOCIAL ISOLATION; VERY ELDERLY; BETACORONAVIRUS; COMMUNICABLE DISEASE CONTROL; CORONAVIRUS INFECTION; DISEASE TRANSMISSION; EPIDEMIC; HEALTH CARE POLICY; MIDDLE AGED; PANDEMIC; PREVENTION AND CONTROL; PROCEDURES; VIRUS PNEUMONIA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BETACORONAVIRUS; CHILD; CHINA; COMMUNICABLE DISEASE CONTROL; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HEALTH POLICY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; YOUNG ADULT;

EID: 85083187947     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2020.6130     Document Type: Article

References (32)

1. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-76. Accessed April 6, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200405-sitrep-76-covid-19.pdf?sfvrsn=6ecf0977-2
2. Guan WJ, Ni ZY, Hu Y,; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. Published online February 28, 2020. doi: 10.1056/NEJMoa2002032 32109013
3. Wang D, Hu B, Hu C, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061-1069. doi: 10.1001/jama.2020.1585 32031570
4. Chen N, Zhou M, Dong X, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395 (10223): 507-513. doi: 10.1016/S0140-6736(20)30211-7 32007143
5. Huang C, Wang Y, Li X, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5 31986264
6. Chang D, Lin M, Wei L, Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020; 323 (11): 1092-1093. doi: 10.1001/jama.2020.1623 32031568
7. Xu XW, Wu XX, Jiang XG, Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368: m606. doi: 10.1136/bmj.m606 32075786
8. Li Q, Guan X, Wu P, Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382 (13): 1199-1207. doi: 10.1056/NEJMoa2001316 31995857
9. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020; 395 (10225): 689-697. doi: 10.1016/S0140-6736(20)30260-9 32014114
10. Kucharski AJ, Russell TW, Diamond C,; Centre for Mathematical Modelling of Infectious Diseases COVID-19 working group. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis. Published online March 11, 2020. doi: 10.1016/S1473-3099(20)30144-4 32171059
11. Li R, Pei S, Chen B, Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. Published online March 16, 2020. doi: 10.1126/science.abb3221 32179701
12. Chinazzi M, Davis JT, Ajelli M, The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020; eaba9757. Published online March 6, 2020. doi: 10.1126/science.aba9757 32144116
13. Tian H, Liu Y, Li Y, An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. Published online March 31, 2020. doi: 10.1126/science.abb6105 32234804
14. National Health Commission of the People's Republic of China. Interim diagnosis and treatment of 2019 novel coronavirus pneumonia. 7th ed. March 3, 2020. Accessed March 4, 2020. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml
15. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020; 323 (8): 709-710. doi: 10.1001/jama.2020.1097 31999307
16. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162 (3): 199-200. doi: 10.1093/aje/kwi188 15987728
17. Cori A, Ferguson NM, Fraser C, Cauchemez S. A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol. 2013; 178 (9): 1505-1512. doi: 10.1093/aje/kwt133 24043437
18. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC Weekly. 2020; 2: 113-122.
19. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323 (13): 1239-1242. doi: 10.1001/jama.2020.2648 32091533
20. Yang X, Yu Y, Xu J, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. S2213-2600(20)30079-5. Published online February 24, 2020. doi: 10.1016/S2213-2600(20)30079-5 32105632
21. Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020; 18: 20. doi: 10.18332/tid/119324 32206052
22. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Accessed March 2, 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
23. Wang G, Zhang Y, Zhao J, Zhang J, Jiang F. Mitigate the effects of home confinement on children during the COVID-19 outbreak. Lancet. 2020; 395 (10228): 945-947. doi: 10.1016/S0140-6736(20)30547-X 32145186
24. Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA. Published online March 12, 2020. doi: 10.1001/jama.2020.3972 32163102
25. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020; 27 (2): taaa021. doi: 10.1093/jtm/taaa021 32052846
26. Chen TM, Rui J, Wang QP, Zhao ZY, Cui JA, Yin L. A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect Dis Poverty. 2020; 9 (1): 24. doi: 10.1186/s40249-020-00640-3 32111262
27. Fong MW, Gao H, Wong JY, Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-social distancing measures. Emerg Infect Dis. 2020; 26 (5). Published online February 6, 2020. doi: 10.3201/eid2605.190995 32027585
28. Bai Y, Yao L, Wei T, Presumed asymptomatic carrier transmission of COVID-19. JAMA. Published online February 21, 2020. doi: 10.1001/jama.2020.2565 32083643
29. Kam KQ, Yung CF, Cui L, A well infant with coronavirus disease 2019 (COVID-19) with high viral load. Clin Infect Dis. 2020; ciaa201. Published online February 28, 2020. doi: 10.1093/cid/ciaa201 32112082
30. Tong ZD, Tang A, Li KF, Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis. 2020; 26 (5). Published online February 6, 2020. doi: 10.3201/eid2605.200198 32091386
31. Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19: studies needed. N Engl J Med. 2020; 382 (13): 1194-1196. doi: 10.1056/NEJMp2002125 32074416
32. Morens DM, Daszak P, Taubenberger JK. Escaping pandora's box-another novel coronavirus. N Engl J Med. 2020; 382 (14): 1293-1295. doi: 10.1056/NEJMp2002106 32101660